As shown in Fig. 3B, using 51 different breast cancer cell lines, we found that TNBC cell lines exhibit higher expression of the cancer stem cell surface marker CD44 and lower expression of the non-CSC CD24 compared with other subtypes. The gene discussed is CD44; the disease is breast cancer.